REPORT ID 6575

EMEA (Europe, Middle East and Africa) Anti-Inflammatory Drugs (NSAIDs) Market Report 2019

Publish Date
2019
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Anti-Inflammatory Drugs (NSAIDs) market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Anti-Inflammatory Drugs (NSAIDs) for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Inflammatory Drugs (NSAIDs) market competition by top manufacturers/players, with Anti-Inflammatory Drugs (NSAIDs) sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie
    Amgen
    AstraZeneca
    Eli Lily
    GlaxoSmithKline
    Roche
    Johnson & Johnson
    Merck
    Novartis
    Pfizer

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Anti-inflammatory Biologics
    Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
    Corticosteroids
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hosptical
    Pharmacy
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Anti-Inflammatory Drugs (NSAIDs) Market  Report 2019
1 Anti-Inflammatory Drugs (NSAIDs) Overview
    1.1 Product Overview and Scope of Anti-Inflammatory Drugs (NSAIDs)
    1.2 Classification of Anti-Inflammatory Drugs (NSAIDs)
        1.2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Anti-inflammatory Biologics
        1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
        1.2.5 Corticosteroids
        1.2.6 Others
    1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Market by Application/End Users
        1.3.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hosptical
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 EMEA Anti-Inflammatory Drugs (NSAIDs) Market by Region
        1.4.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Anti-Inflammatory Drugs (NSAIDs) ( 2014-2024)
        1.5.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate ( 2014-2024)

2 EMEA Anti-Inflammatory Drugs (NSAIDs) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Competition by Players/Manufacturers
        2.1.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price by Players ( 2014-2019)
    2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Type/Product Category
        2.2.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sale Price by Type ( 2014-2019)
    2.3 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume) by Application
    2.4 EMEA Anti-Inflammatory Drugs (NSAIDs) (Volume and Value) by Region
        2.4.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Price by Region ( 2014-2019)

3 Europe Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Value ( 2014-2019)
        3.1.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
    3.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
    3.4 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries ( 2014-2019)
        3.4.3 Germany Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        3.4.4 France Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)

4 Middle East Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Value ( 2014-2019)
        4.1.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
    4.3 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
    4.4 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)

5 Africa Anti-Inflammatory Drugs (NSAIDs) (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Value ( 2014-2019)
        5.1.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Type
    5.3 Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Market Share by Application
    5.4 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Anti-Inflammatory Drugs (NSAIDs) Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate ( 2014-2019)

6 EMEA Anti-Inflammatory Drugs (NSAIDs) Manufacturers/Players Profiles and Sales Data
    6.1 AbbVie
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AbbVie Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Amgen
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Amgen Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 AstraZeneca
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 AstraZeneca Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Eli Lily
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Eli Lily Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 GlaxoSmithKline
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GlaxoSmithKline Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Roche
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Roche Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Johnson & Johnson
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson & Johnson Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Merck
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Novartis
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Novartis Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Pfizer
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Anti-Inflammatory Drugs (NSAIDs) Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Pfizer Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview

7 Anti-Inflammatory Drugs (NSAIDs) Manufacturing Cost Analysis
    7.1 Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anti-Inflammatory Drugs (NSAIDs)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anti-Inflammatory Drugs (NSAIDs) Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Anti-Inflammatory Drugs (NSAIDs) Market Forecast ( 2019-2025)
    11.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Anti-Inflammatory Drugs (NSAIDs) Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer